inTEST amends 8-K for Alfamation acquisition: lease corrected, financials filing waived

INTEST CORP

Base purchase price approx. €20M: €18M cash + 187,432 shares + ~€542K for excess assets.
Lease corrected to €260K/year (paid semiannually) for 51,817 sq ft, 6-year term renewable.
Company determines no separate financial statements or pro forma required for Alfamation acquisition.
Amendment addresses typographical error in lease payment and removes Item 9.01 filing obligation.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.99

INTEST CORP entered into Purchase Agreement with Mauro Arigossi; Elettra S.S. valued at approximately €20 million (effective 2024-03-12).

Action: entry
Agreement: asset purchase
Counterparty: Mauro Arigossi; Elettra S.S.
Value: approximately €20 million
Effective: 2024-03-12

Exact text from the filing

On March 12, 2024 inTEST Corporation (the “Company”) entered into a stock purchase agreement (the “Purchase Agreement”) by and among inTEST Italy, Inc., a wholly owned subsidiary of the Company (“Buyer”), Mauro Arigossi (“Arigossi”), and Elettra S.S., a company incorporated under the Laws of Italy (“Elettra”, and together with Arigossi, each a “Seller” and collectively, the “Sellers”).

View on SEC.gov

324 material agreements filed in the last 30 days. Browse all material agreements →

INTEST CORP filing history →

Source: SEC EDGAR

accession 0001437749-24-016634

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.